102 related articles for article (PubMed ID: 36412402)
21. Do rural patients with operable breast cancer fare worse than urban patients in Louisiana? Results of the Louisiana cancer consortium.
Chu QD; Hsieh MC; Chu Y; Lyons J; Kandil E; Corsetti R; White RK; Gnerlich JL; Wu XC
Surgery; 2020 Oct; 168(4):653-661. PubMed ID: 32622472
[TBL] [Abstract][Full Text] [Related]
22. Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.
Lutgendorf SK; Mullen-Houser E; Russell D; Degeest K; Jacobson G; Hart L; Bender D; Anderson B; Buekers TE; Goodheart MJ; Antoni MH; Sood AK; Lubaroff DM
Brain Behav Immun; 2010 Nov; 24(8):1231-40. PubMed ID: 20600809
[TBL] [Abstract][Full Text] [Related]
23. Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand.
Tharavichitkul E; Lorvidhaya V; Kamnerdsupaphon P; Sukthomya V; Chakrabandhu S; Klunklin P; Onchan W; Supawongwattana B; Pukanhaphan N; Galalae R; Chitapanarux I
BMC Cancer; 2016 Jul; 16():501. PubMed ID: 27435245
[TBL] [Abstract][Full Text] [Related]
24. Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.
Ziebarth AJ; Smith H; Killian ME; Nguyen NA; Durst JK; Subramaniam A; Kim KH; Leath CA; Straughn JM; Alvarez RD
Gynecol Oncol; 2012 Jul; 126(1):69-72. PubMed ID: 22484400
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer.
Morgenthaler J; Köhler C; Budach V; Sehouli J; Stromberger C; Besserer A; Trommer M; Baues C; Marnitz S
Strahlenther Onkol; 2021 Jun; 197(6):474-486. PubMed ID: 32970164
[TBL] [Abstract][Full Text] [Related]
26. Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam.
Phung HT; Truong MC; Nguyen LT; Dang ATV; Vu TH; Nguyen HT
Asian Pac J Cancer Prev; 2021 Mar; 22(3):853-859. PubMed ID: 33773550
[TBL] [Abstract][Full Text] [Related]
27. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B
Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631
[TBL] [Abstract][Full Text] [Related]
28. The promise of image-guided brachytherapy of better clinical outcomes in treatment of cervical cancer: Does it deliver? An Indian scenario.
Tiwari R; Narayanan GS; Jayakumar V; Narayanan S; Vishwanathan B; Mandal SK; Babu S; Ramya V; George D
Gynecol Oncol; 2018 Sep; 150(3):420-425. PubMed ID: 30017538
[TBL] [Abstract][Full Text] [Related]
29. Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
Lin AJ; Samson P; Zoberi J; Garcia-Ramirez J; Williamson JF; Markovina S; Schwarz J; Grigsby PW
Brachytherapy; 2019; 18(3):353-360. PubMed ID: 30971370
[TBL] [Abstract][Full Text] [Related]
30. Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?
Walji N; Chue AL; Yap C; Rogers LJ; El-Modir A; Chan KK; Singh K; Fernando IN
Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):140-6. PubMed ID: 20045300
[TBL] [Abstract][Full Text] [Related]
31. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
Grover S; Ning MS; Bale M; Lichter KE; Shah S; Bvochora-Nsingo M; Chiyapo S; Balang D; McGinnis GJ; Ralefala T; Moloi T; Luckett R; Ramogola-Masire D; Robertson ES; Zetola NM
Int J Gynecol Cancer; 2021 Sep; 31(9):1220-1227. PubMed ID: 34312220
[TBL] [Abstract][Full Text] [Related]
32. Comparisons of Papanicolaou Utilization and Cervical Cancer Detection between Rural and Urban Women in Taiwan.
Yang CM; Sung FC; Hsue CS; Muo CH; Wang SW; Shieh SH
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33379209
[TBL] [Abstract][Full Text] [Related]
33. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
[TBL] [Abstract][Full Text] [Related]
35. Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients.
Spees LP; Brewster WR; Varia MA; Weinberger M; Baggett C; Zhou X; Petermann VM; Wheeler SB
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):882-889. PubMed ID: 30733307
[TBL] [Abstract][Full Text] [Related]
36. A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma.
Nanda R; Katke A; Suneetha N; Thejaswini B; Pasha T; Jagannath KP; Giri GV; Babu KG
South Asian J Cancer; 2019; 8(3):178-182. PubMed ID: 31489293
[TBL] [Abstract][Full Text] [Related]
37. Low-Dose-Rate Brachytherapy Boosting Concurrent Chemoradiation as a Definitive Treatment Modality for Cervical Cancer: Long-term Clinical Results of Outcomes and Associated Toxicity.
Refaat T; Donnelly ED; Gentile M; Novak C; Yuan Y; Khedr GA; Helenowksi I; Lurain J; Schink J; Rademaker A; Sathiaseelan V; Strauss JB; Small W
Am J Clin Oncol; 2016 Apr; 39(2):196-203. PubMed ID: 24487420
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.
Spees LP; Wheeler SB; Varia M; Weinberger M; Baggett CD; Zhou X; Petermann VM; Brewster WR
Gynecol Oncol; 2019 Jan; 152(1):112-118. PubMed ID: 30442384
[TBL] [Abstract][Full Text] [Related]
39. The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer.
Yoshida K; Kajiyama H; Yoshihara M; Tamauchi S; Ikeda Y; Yoshikawa N; Nishino K; Niimi K; Suzuki S; Kikkawa F
Int J Clin Oncol; 2020 Feb; 25(2):384-390. PubMed ID: 31552530
[TBL] [Abstract][Full Text] [Related]
40. Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
Hung P; Deng S; Zahnd WE; Adams SA; Olatosi B; Crouch EL; Eberth JM
Cancer; 2020 Mar; 126(5):1068-1076. PubMed ID: 31702829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
